Showing results (11-20 of 142) with videos related to
Sort By:
Pageof 15
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 9, 1998
Rationale and pharmacology of angiotensin II receptor antagonists: current status and future issuesC I Johnston, M Naitoh, L M BurrellJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1993
Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosteroneA M Abdelrahman, L M Burrell, C I JohnstonScandinavian Journal of Clinical and Laboratory Investigation|December 1, 1991
Is the fluorescein dilaurate test suitable for monitoring the effectiveness of pancreatic enzyme replacement therapy?L M Burrell, E J Boyd, K G WormsleyClinical Endocrinology|September 1, 1991
The effect of drinking on atrial natriuretic peptide, vasopressin and thirst appreciation in hyperosmolar manL M Burrell, H J Lambert, P H BaylisThe American Journal of Physiology|March 10, 1999
Vasopressin V2 receptor enhances gain of baroreflex in conscious spontaneously hypertensive ratsD B Sampey, L M Burrell, R E WiddopJournal of Hypertension|June 29, 2000
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRsN K Farina, C I Johnston, L M BurrellThe American Journal of Physiology|March 1, 1991
Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humansL M Burrell, H J Lambert, P H BaylisClinical Science (London, England : 1979)|July 1, 1992
Atrial natriuretic peptide inhibits fluid intake in hyperosmolar subjectsL M Burrell, J M Palmer, P H BaylisEuropean Journal of Pharmacology|October 21, 1999
In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the ratJ Risvanis, M Naitoh, C I Johnston, et al.Journal of Occupational and Environmental Medicine|June 24, 1998
Occupational upper extremity disorders in the federal workforce. Prevalence, health care expenditures, and patterns of work disabilityM Feuerstein, V L Miller, L M Burrell, et al.Pageof 15